Most Viewed Articles

Articles Information
Articles Fulltext downloads PDF downloads
Editorial: Misleading and Biased Lancet Editorial on Kashmir: What are the Authors Hiding?
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
1886 737
Review Article: Biomarkers in immuno-oncology: A review article
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
2200 417
Review Article: Immunotherapy in esophageal cancer – An update
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
1819 382
Original Article: Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
1484 678
Original Article: Indian Surgeons’ Perspective Regarding Breast-Conserving Surgery: A Cohort Study
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
1415 654
Editorial: Nanobytes
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
1340 699
Conference Review: 4 molecular oncology conference (MOSCON): Untangling the genetic code
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
1124 313
Review Article: Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent hybridization and Immunohistochemistry: A meta-analysis with systematic review
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
928 479
Review Article: Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
953 413
Case Report: Complete metabolic response with letrozole and palbociclib in advanced breast cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
1132 229
Review Article: Role of molecular diagnostics in determination of tissue of origin in Cancer of Unknown Primary (CUP)
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
1008 259
Case Report: Chronic myelomonocytic leukemia-1 in a post-renal transplant patient
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
823 434
Response to the letter: Artificial intelligence: A new era of technological advancement in oncology care
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
848 405
Case Report: An unusual synchronous association of chronic myeloid leukemia with carcinoma tongue
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
872 374
Original Article: Evaluation of prevalence and prognostic significance of human epidermal growth factor receptor 2/neu expression in carcinoma endometrium
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
780 458
Original Article: Correlation of Biomarkers and Frozen Section Diagnosis with Paraffin Histopathological Diagnosis in Suspected Ovarian Cancer
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 3, September-December
995 229
Editorial: Nanobyte: Molecular and immuno oncology update
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 2, May-Aug, 2019
759 321
Conference Review: Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology – A present status
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
813 181
Editorial: Immune checkpoint inhibitor – antiangiogenic drugs combination in treatment-naïve metastatic clear cell renal cell carcinoma: Why should immunotherapy have all the fun!
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2020, Volume: 5, Issue: 1, January-April
848 133
Letter to Editor: Artificial intelligence: A new era of technological advancement in oncology care
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
699 195
Original Article: Special considerations for consent in immuno-oncology – Medic LAWgic recommendations
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
698 182
Original Article: Multiple gene silencing in pathway in K562 cells
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
603 137
Editorial: Nanobyte – Perspectives and milestones in molecular biology and immuno-oncology
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
433 163
Original Article: Oral cancers – Micronuclei as biomarker of genotoxicity a population-based study to establish usable dynamic cut off limits in tobacco users
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
431 127
Position Paper: Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy
Full text New Window Icon | PDF IconPDF New Window Icon 
Year: 2019, Volume: 4, Issue: 1, January-April
405 144